Genfleet Therapeutics (Shanghai), Inc. Class H

Genfleet Therapeutics (Shanghai), Inc. Class H's next confirmed earnings release is scheduled for March 24, 2027.

As of December 31, 2025, Genfleet Therapeutics (Shanghai), Inc. Class H has 370.37M shares outstanding.

As of December 31, 2025, Genfleet Therapeutics (Shanghai), Inc. Class H maintains a current ratio of 5.85, meaning it holds 5.8x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

These figures are as of the close on October 22, 2026.

As of December 31, 2025, Genfleet Therapeutics (Shanghai), Inc. Class H holds 252.52M in cash and equivalents against 12.28M in total debt, resulting in a net debt position of -135.53M. Total book value stands at 220.86M, with working capital of 218.11M providing operational flexibility.